Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenvironment to enhance the body’s antitumor immunity.

Sectors
Healthcare
Life Sciences
First Invested
2017
Early
Company Status
Acquired by Ikena
Associated Team
J.C. Lopez, MD